GE Infant Warmer Recalled Due to Oxygen Mixer Problems

|

A recall has been issued for resuscitation systems installed in infant warmers, due to a possible manufacturing error that may reverse the oxygen mixing concentrations, posing a risk of serious and potentially life-threatening injuries for infants receiving the treatment.

GE Healthcare notified consumers in October 2012 about potential problems’s with the company’s resuscitation systems with blenders, which are installed in GE Giraffe and Panda infant warmers. However, the FDA determined last week that the action constitutes a Class I medical device recall, suggesting that continued use of the resuscitation systems carries a reasonable probability of serious adverse health consequences or death.

The oxygen and air inlet fittings and labels located on the back panel of the device may have been reversed during assembly, which could cause the air and oxygen concentrations to potentially reverse. As a result, the setting of the blender knob may not inaccurately reflect the amount of oxygen produced.

Hair-Dye-Cancer-Lawsuits
Hair-Dye-Cancer-Lawsuits

The recall consists of field upgrade kits for GE Healthcare’s resuscitation systems with blender, installed in GE Giraffe and Panda infant warmers manufactured between April 2008 and September 2012.

GE Healthcare began notifying customers with affected units by sending an “Urgent Medical Device” letter in October, consisting of instructions and illustrations to allow hospital personnel to inspect and correct the device immediately and how to confirm their receipt of the letter.

Consumers with affected products should stop using the product immediately and contact GE Healthcare Customer Service at 1-800-345-2700 to schedule an inspection and mitigation.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery.
As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025.
Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case.